Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Elisa Molinelli, Claudia Sapigni, Anna Campanati, Valerio Brisigotti & Annamaria Offidani. (2020) Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa. Expert Opinion on Drug Metabolism & Toxicology 16:11, pages 1019-1037.
Read now
Read now
Vassiliki Tzanetakou, Dimitra Stergianou & Evangelos J. Giamarellos-Bourboulis. (2020) Long-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativa. Expert Opinion on Drug Safety 19:4, pages 381-393.
Read now
Read now
Shi Yu Derek Lim & Hazel H Oon. (2019) Systematic review of immunomodulatory therapies for hidradenitis suppurativa. Biologics: Targets and Therapy 13, pages 53-78.
Read now
Read now
Simon Francis Thomsen. (2018) A note on improvement in dermatology life quality index (DLQI) among patients with hidradenitis suppurativa treated with adalimumab. Journal of Dermatological Treatment 29:8, pages 823-824.
Read now
Read now
Malgorzata Ponikowska, Lukasz Matusiak & Jacek C. Szepietowski. (2017) Current systemic treatment strategies for hidradenitis suppurativa. Expert Opinion on Orphan Drugs 5:3, pages 241-251.
Read now
Read now
Christos C. Zouboulis. (2016) Adalimumab for the treatment of hidradenitis suppurativa/acne inversa. Expert Review of Clinical Immunology 12:10, pages 1015-1026.
Read now
Read now
Deirdre Nathalie Dufour, Solveig Esmann & Gregor BE Jemec. (2012) Improving quality of life in patients with hidradenitis suppurativa: a therapeutic view. Expert Review of Dermatology 7:6, pages 549-557.
Read now
Read now
Articles from other publishers (34)
Terri Shih, Katrina Lee, Tristan Grogan, Devea R. De, Vivian Y. Shi & Jennifer L. Hsiao. (2022) Infliximab in hidradenitis suppurativa: A systematic review and meta‐analysis. Dermatologic Therapy 35:9.
Crossref
Crossref
Linnea Lackstrom Westerkam, Kelly Jo Tackett & Christopher John Sayed. (2021) Comparing the Effectiveness and Safety Associated With Infliximab vs Infliximab-abda Therapy for Patients With Hidradenitis Suppurativa. JAMA Dermatology 157:6, pages 708.
Crossref
Crossref
Meng Zhang, Qun-De Chen, Hai-Xia Xu, Yu-Meng Xu, Hong-Jin Chen & Bo-Lin Yang. (2021) Association of hidradenitis suppurativa with Crohn’s disease. World Journal of Clinical Cases 9:15, pages 3506-3516.
Crossref
Crossref
Judy Hamad, Benjamin J. McCormick, Christopher J. Sayed, Karina Paci, Matthew Overton, Thomas Daubert & Bradley D. Figler. (2020) Multidisciplinary Update on Genital Hidradenitis Suppurativa. JAMA Surgery 155:10, pages 970.
Crossref
Crossref
Mondana H. Ghias, Andrew D. Johnston, Allison J. Kutner, Robert G. Micheletti, H. Dean Hosgood & Steven R. Cohen. (2020) High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa. Journal of the American Academy of Dermatology 82:5, pages 1094-1101.
Crossref
Crossref
Emily Nesbitt, Stephanie Clements & Marcia Driscoll. (2020) A concise clinician’s guide to therapy for hidradenitis suppurativa. International Journal of Women's Dermatology 6:2, pages 80-84.
Crossref
Crossref
Lauren A.V. Orenstein, Tien V. Nguyen, Giovanni Damiani, Christopher Sayed, Gregor B.E. Jemec & Iltefat Hamzavi. (2020) Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice. Dermatology 236:5, pages 393-412.
Crossref
Crossref
Christos C. Zouboulis, Hendrik Hansen, Raffaele Dante Caposiena Caro, Giovanni Damiani, Isabelle Delorme, José Carlos Pascual, Ziad Reguiai, Anastasia Trigoni, Eva Vilarrasa & Fernando Alfageme Roldán. (2020) Adalimumab Dose Intensification in Recalcitrant Hidradenitis Suppurativa/Acne Inversa. Dermatology 236:1, pages 25-30.
Crossref
Crossref
Jewell V. Gaulding & Diane Jackson-Richards. 2020. Practical Guide to Dermatology. Practical Guide to Dermatology
131
143
.
Ashley N. Oskardmay, J. Alex Miles & Christopher J. Sayed. (2019) Determining the optimal dose of infliximab for treatment of hidradenitis suppurativa. Journal of the American Academy of Dermatology 81:3, pages 702-708.
Crossref
Crossref
Ali Alikhan, Christopher Sayed, Afsaneh Alavi, Raed Alhusayen, Alain Brassard, Craig Burkhart, Karen Crowell, Daniel B. Eisen, Alice B. Gottlieb, Iltefat Hamzavi, Paul G. Hazen, Tara Jaleel, Alexa B. Kimball, Joslyn Kirby, Michelle A. Lowes, Robert Micheletti, Angela Miller, Haley B. Naik, Dennis Orgill & Yves Poulin. (2019) North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Journal of the American Academy of Dermatology 81:1, pages 91-101.
Crossref
Crossref
Katarzyna Włodarek, Małgorzata Ponikowska, Łukasz Matusiak & Jacek C Szepietowski. (2019) Biologics for hidradenitis suppurativa: an update. Immunotherapy 11:1, pages 45-59.
Crossref
Crossref
Kevin T. Savage, Kelsey S. Flood, Martina L. Porter & Alexa B. Kimball. (2019) TNF-α inhibitors in the treatment of hidradenitis suppurativa. Therapeutic Advances in Chronic Disease 10, pages 204062231985164.
Crossref
Crossref
Costas A Constantinou, George E Fragoulis & Elena Nikiphorou. (2019) Hidradenitis suppurativa: infection, autoimmunity, or both?. Therapeutic Advances in Musculoskeletal Disease 11, pages 1759720X1989548.
Crossref
Crossref
E. Delany, G. Gormley, R. Hughes, S. McCarthy, S. Kirthi, T. Markham, A.-M. Tobin, M. Murphy & B. Kirby. (2018) A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP). Journal of the European Academy of Dermatology and Venereology 32:3, pages 467-473.
Crossref
Crossref
A. PinkF. Anzengruber & A.A. Navarini. (2018) Acne and hidradenitis suppurativa. British Journal of Dermatology 178:3, pages 619-631.
Crossref
Crossref
E. Robert, F. Bodin, C. Paul, M.-P. Konstantinou, Y. Gall, J.-L. Grolleau, J. Laloze & B. Chaput. (2017) Non-surgical treatments for hidradenitis suppurativa: A systematic review. Annales de Chirurgie Plastique Esthétique 62:4, pages 274-294.
Crossref
Crossref
Andrew F. Alexis & Bridget P. Kaufman. 2017. Dermatoanthropology of Ethnic Skin and Hair. Dermatoanthropology of Ethnic Skin and Hair
359
387
.
J. Kirschke, S. Hessam & F. G. Bechara. (2015) Hidradenitis suppurativa/Acne inversaHidradenitis suppurativa/acne inversa. coloproctology 38:3, pages 159-168.
Crossref
Crossref
J.L. Blok, K. LiC. BrodmerkelP. Horvátovich, M.F. Jonkman & B. Horváth. (2016) Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum. British Journal of Dermatology 174:4, pages 839-846.
Crossref
Crossref
I. E. Deckers & E. P. Prens. (2015) An Update on Medical Treatment Options for Hidradenitis Suppurativa. Drugs 76:2, pages 215-229.
Crossref
Crossref
Jean E. Revuz & Gregor B.E. Jemec. (2016) Diagnosing Hidradenitis Suppurativa. Dermatologic Clinics 34:1, pages 1-5.
Crossref
Crossref
Carina M. Woodruff, Abbas M. Charlie & Kieron S. Leslie. (2015) Hidradenitis Suppurativa. Mayo Clinic Proceedings 90:12, pages 1679-1693.
Crossref
Crossref
Antonia Brandt, Annett Milling & Christos C. Zouboulis. (2015) Langwierige Diagnose, hohe Rezidivrate. hautnah dermatologie 31:6, pages 40-47.
Crossref
Crossref
Hans Christian Ring, Peter Riis Mikkelsen, Iben Marie Miller, Håvard Jenssen, Kurt Fuursted, Ditte Marie Saunte & Gregor B.E. Jemec. (2015) The bacteriology of hidradenitis suppurativa: a systematic review. Experimental Dermatology 24:10, pages 727-731.
Crossref
Crossref
Valentina Dini, Teresa Oranges, Luca Rotella & Marco Romanelli. (2015) Hidradenitis Suppurativa and Wound Management. The International Journal of Lower Extremity Wounds 14:3, pages 236-244.
Crossref
Crossref
J. Kirschke, S. Hessam & F.G. Bechara. (2015) Hidradenitis suppurativa/Acne inversaHidradenitis suppurativa/acne inversa. Der Hautarzt 66:6, pages 413-422.
Crossref
Crossref
C.C. Zouboulis, N. Desai, L. Emtestam, R.E. Hunger, D. Ioannides, I. Juhász, J. Lapins, L. Matusiak, E.P. Prens, J. Revuz, S. Schneider-Burrus, J.C. Szepietowski, H.H. van der Zee & G.B.E. Jemec. (2015) European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. Journal of the European Academy of Dermatology and Venereology 29:4, pages 619-644.
Crossref
Crossref
Alexandros C. Katoulis, Dimitra Koumaki, Aikaterini I. Liakou, Georgia Vrioni, Vasiliki Koumaki, Dimitra Kontogiorgi, Korina Tzima, Athanasios Tsakris & Dimitris Rigopoulos. (2015) Aerobic and Anaerobic Bacteriology of Hidradenitis Suppurativa: A Study of 22 Cases. Skin Appendage Disorders 1:2, pages 55-59.
Crossref
Crossref
J. Zhang, V.J. Reeder & I.H. Hamzavi. (2014) Use of biologics in the treatment of hidradenitis suppurativa: a review of the Henry Ford Hospital experience. British Journal of Dermatology 171:6, pages 1600-1602.
Crossref
Crossref
Niranthari Chinniah & Geoffrey David Cains. (2014) Moderate to severe hidradenitis suppurativa treated with biological therapies. Australasian Journal of Dermatology 55:2, pages 128-131.
Crossref
Crossref
Constanza Bahillo Monné, Silvia Honorato Guerra, Cristina Schoendorff Ortega & Ana Belen Gargallo Quintero. (2014) Management of Hidradenitis Suppurativa with Biological Therapy: Report of Four Cases and Review of the Literature. Dermatology 229:4, pages 279-287.
Crossref
Crossref
David Chandler & Anthony Bewley. (2013) Biologics in Dermatology. Pharmaceuticals 6:4, pages 557-578.
Crossref
Crossref
J.L. Blok, S. van Hattem, M.F. Jonkman & B. Horváth. (2013) Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review. British Journal of Dermatology 168:2, pages 243-252.
Crossref
Crossref